Skip to main content
. 2022 Feb 8;7(3):e145653. doi: 10.1172/jci.insight.145653

Figure 2. Reduced natriuresis to the ENaC blocker amiloride in Epac1–/–, Epac2–/–, and Epac1&2–/– mice.

Figure 2

Summary graphs comparing urinary Na+ levels (A) and K+ levels (B) in Epac WT, Epac1–/–, Epac2–/–, and Epac1&2–/– mice kept on Na+-deficient diet for 7 days at the baseline and following i.p. injection of amiloride (2 mg/kgBW). Measurements from the same animal are connected with lines. In both cases, urine samples were collected over a 6-hour period. Relative reductions (in %) in urinary K+ levels are shown for each tested group. *P < 0.05 versus Epac WT mice + Amiloride; 1-way ANOVA with post hoc Tukey test was used.